APN inhibited the angiotensin type-1 receptor (AT1R), inflammatory cytokine and mast cell protease expression, and induced upregulation of LOX in the aortic wall, improved systemic cytokine profile and attenuated adipose inflammation, thus preventing AAA. The gene discussed is AGTR1; the disease is triple-A syndrome.